Efficacy of M640 in Acute Lumbosacral Musculoskeletal Conditions.
Primus Pharmaceuticals · with Illumination Health · NCT06157177
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–80 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 50
- US sites recruiting
- 8
- Study start
- November 15, 2023
- Record last updated
- September 14, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to learn if a modification to metaxalone 640 mg can reduce low back and leg pain. The participants will be 18 to 80 years old, healthy with newly occurring back or leg pain. The main question aims to compare a group taking active treatment and a group taking a look-alike substance containing no active treatment. All participants will answer questions on Day 1, before treatment, and on 7-day after treatment, about:
- Amount and quality of pain
- Interference with physical activity
- Interference with sleep
Being studied: Metaxalone 640 mg Oral Tablet
Conditions: Sciatica Acute; Lumbar Spinal Stenosis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- No clinically significant conditions impacting quality or quantity of pain
- Baseline Numeric Pain Scale ≥ 6
- Capable of answering text or email survey reminders
- Low back pain with or without sciatica
Exclusion Criteria
- Current use of other skeletal relaxants
- Current use of other pain relievers
- Current use of cimetidine or monoamine oxidase inhibitors
Recruiting US locations
Robert Levin, MD
Clearwater, FL 33765
Site contact: simi@illumination.health
5. CZ Rheumatology
Coral Springs, FL 33065
Site contact: simi@illumination.health
Arthritis and Osteoporosis Treatment and ResearchCenter
Miami, FL 33180
Site contact: George Munoz, MD · simi@illumination.health
CZ Rheumatology
Miami Beach, FL 33140
Site contact: Conrad Ziembinski, DO · simi@illumination.health
Bay Area Rheumatology
Oldsmar, FL 34677
Site contact: Rodney Daniel,, MD · simi@illumination.health
Arthritis and Rheumatology Center of MI
Sterling Heights, MI 48310
Site contact: Srijana Bakshi, MD · simi@illumination.health
Cumberland Rheumatology
Crossville, TN 38555
Site contact: Sivalingam Kanagasegar, MD · simi@illumination.health
Heritage Rheumatology & Arthritis Care
Colleyville, TX 76034
Site contact: simi@illumination.health
Study contacts (from the official record)
- S Sodhi · 205-202-0739 · simi@illumination.health
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65